In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B
about
Host recognition of Clostridium difficile and the innate immune response.Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model.Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin AVancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea.Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile InfectionsGlucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer.Antibodies for treatment of Clostridium difficile infection.Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.Innate immune response and outcome of Clostridium difficile infection are dependent on fecal bacterial composition in the aged host.The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.Effects of Clostridium difficile toxin A on K562/A02 cell proliferation, apoptosis and multi-drug resistance.Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting.Cysteine Protease-Mediated Autocleavage of Clostridium difficile Toxins Regulates Their Proinflammatory Activity.
P2860
Q27026464-9197B402-BB61-4746-8303-43CFCB3A51FFQ27303623-BF7B09A5-7A90-4E16-8750-4E2108001351Q30276645-94F180BC-69A1-433D-A474-54C7D2D26145Q30277264-0162F2BB-2BD9-43F3-B012-A36B732C2DA3Q30300865-527521D1-DCDF-49AE-9B93-479D4D3E1D67Q30301156-7BB7CF04-49EF-4A7A-A8B5-CC3ED8D9C6D0Q34453038-DC3AFFDB-295C-45F2-994C-732E67B7697EQ35676296-BF305BC5-E5B8-4E3D-865D-59D71CFD2813Q36189901-C4FECB51-114F-446B-8CAF-D5DAAD6C53EAQ36823908-D3AD5E05-6664-4287-83ED-70D30D75E00AQ38208794-511DCBED-FF94-44AA-ADF3-2BD58CC9FB2BQ38797967-191E7508-42F8-41E2-90A2-6F21BFB56815Q45068991-8C1BC3E1-7EE2-4B71-8FAD-8D48DF75DC26Q49282081-481203C7-159A-4CDD-B9FC-C9D80479373EQ52653036-3636D8FD-AC4A-4C82-8880-AE35DFBF86F1Q54239070-C47FD190-AD3B-45B1-BBCA-ADD74B2873DFQ55279053-EB8C9EF8-F581-4A00-BEC4-BA18AA96956B
P2860
In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vivo physiological and tran ...... difficile toxin A and toxin B
@ast
In vivo physiological and tran ...... difficile toxin A and toxin B
@en
type
label
In vivo physiological and tran ...... difficile toxin A and toxin B
@ast
In vivo physiological and tran ...... difficile toxin A and toxin B
@en
prefLabel
In vivo physiological and tran ...... difficile toxin A and toxin B
@ast
In vivo physiological and tran ...... difficile toxin A and toxin B
@en
P2093
P2860
P50
P356
P1476
In vivo physiological and tran ...... difficile toxin A and toxin B
@en
P2093
Erik L Hewlett
Gina M Donato
Kevin M D'Auria
Mary C Gray
P2860
P304
P356
10.1128/IAI.00869-13
P407
P577
2013-07-29T00:00:00Z